• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在非流行期,确诊癌症患者入院当天直肠拭子中编码vanA/vanB万古霉素耐药性的基因发生率。

Incidence of genes encoding vanA/vanB vancomycin resistance in rectal swabs of patients with diagnosed cancer, on the day of admission to hospital, in a non-epidemic period.

作者信息

Szymankiewicz Maria, Wróblewska Joanna, Nowikiewicz Tomasz

机构信息

Department of Microbiology, Prof. F. Łukaszczyk Centre of Oncology, Bydgoszcz, Poland.

Chair and Clinic of Oncological Surgery, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland.

出版信息

Prz Gastroenterol. 2020;15(3):220-224. doi: 10.5114/pg.2020.98537. Epub 2020 Sep 19.

DOI:10.5114/pg.2020.98537
PMID:33005267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7509899/
Abstract

INTRODUCTION

Rapid diagnosis is important for preventing infections due to vancomycin-resistant enterococci.

AIM

To evaluate the status of gastrointestinal colonisation with strains containing vanA/vanB genes in oncological patients.

MATERIAL AND METHODS

A total of 167 samples of rectal swabs taken from 161 patients (mean age: 63, range: 29-93 years) were examined, including 113 patients from surgical wards (70.2%) and 48 patients from non-surgical wards (29.8%), with diagnosed cancer. The tests were carried out within 24 h of admitting the patient to the department, using the Cepheid Xpert vanA/vanB test, with a CE marked GeneXpert Instrument Systems analyser. Samples with positive vanB gene results were additionally seeded on chromogenic media.

RESULTS

The presence of the vanA gene was found in 2.7% and 6.3% of the examined patients, respectively, from the surgical and non-surgical departments, which accounted for 3.7% of all the patients examined. The presence of the vanB gene was detected in 21.1% of the patients, but in no case was there any growth of vancomycin-resistant enterococci on the chromogenic medium.

CONCLUSIONS

Patients admitted to non-surgical wards were more often colonised with vanA/vanB genes than were patients admitted to surgical wards, but the differences were not statistically significant.

摘要

引言

快速诊断对于预防耐万古霉素肠球菌感染很重要。

目的

评估肿瘤患者中携带vanA/vanB基因菌株的胃肠道定植情况。

材料与方法

共检查了161例患者(平均年龄:63岁,范围:29 - 93岁)的167份直肠拭子样本,其中包括113例来自外科病房的患者(70.2%)和48例来自非外科病房的患者(29.8%),均已确诊患有癌症。在患者入院科室后的24小时内进行检测,使用赛沛Xpert vanA/vanB检测,采用带有CE标志的GeneXpert仪器系统分析仪。vanB基因检测结果为阳性的样本另外接种在显色培养基上。

结果

在来自外科和非外科科室的受检患者中,分别有2.7%和6.3%的患者检测到vanA基因,占所有受检患者的3.7%。在21.1%的患者中检测到vanB基因,但在显色培养基上均未发现耐万古霉素肠球菌生长。

结论

入住非外科病房的患者比入住外科病房的患者更常携带vanA/vanB基因,但差异无统计学意义。

相似文献

1
Incidence of genes encoding vanA/vanB vancomycin resistance in rectal swabs of patients with diagnosed cancer, on the day of admission to hospital, in a non-epidemic period.在非流行期,确诊癌症患者入院当天直肠拭子中编码vanA/vanB万古霉素耐药性的基因发生率。
Prz Gastroenterol. 2020;15(3):220-224. doi: 10.5114/pg.2020.98537. Epub 2020 Sep 19.
2
Pitfalls in the identification of Enterococcus species and the detection of vanA and vanB genes.肠球菌属菌种鉴定及vanA和vanB基因检测中的陷阱。
Lett Appl Microbiol. 2016 Sep;63(3):189-95. doi: 10.1111/lam.12610. Epub 2016 Aug 5.
3
Efficiency of the Cepheid Xpert vanA/vanB assay for screening of colonization with vancomycin-resistant enterococci during hospital outbreak.Cepheid Xpert vanA/vanB assay 在医院爆发期间筛查耐万古霉素肠球菌定植的效率。
Antonie Van Leeuwenhoek. 2012 Mar;101(3):671-5. doi: 10.1007/s10482-011-9681-z. Epub 2011 Nov 29.
4
[Comparison of GeneXpert® vanA/vanB PCR system and culture methods in the surveillance of vancomycin-resistant enterococci].GeneXpert® vanA/vanB聚合酶链反应系统与培养方法在耐万古霉素肠球菌监测中的比较
Mikrobiyol Bul. 2014 Oct;48(4):538-44. doi: 10.5578/mb.8848.
5
Rapid identification of the vanA/vanB resistance determinant in Enterococcus sp. from blood cultures using the Cepheid Xpert vanA/vanB cartridge system.采用 Cepheid Xpert vanA/vanB 检测试剂盒系统快速鉴定血培养肠球菌属中 vanA/vanB 耐药决定因子。
Diagn Microbiol Infect Dis. 2020 Apr;96(4):114977. doi: 10.1016/j.diagmicrobio.2019.114977. Epub 2019 Dec 27.
6
Diagnostic accuracy of the Cepheid GeneXpert vanA/vanB assay ver. 1.0 to detect the vanA and vanB vancomycin resistance genes in Enterococcus from perianal specimens.Cepheid GeneXpert vanA/vanB 检测法 1.0 版检测肛周标本肠球菌中 vanA 和 vanB 万古霉素耐药基因的诊断准确性。
Diagn Microbiol Infect Dis. 2011 Apr;69(4):382-9. doi: 10.1016/j.diagmicrobio.2010.11.005.
7
Outbreak in a haematology unit involving an unusual strain of glycopeptide-resistant Enterococcus faecium carrying both vanA and vanB genes.血液科病房中出现一株携带 vanA 和 vanB 基因的万古霉素耐药肠球菌,属罕见菌株。
J Antimicrob Chemother. 2014 Feb;69(2):500-5. doi: 10.1093/jac/dkt376. Epub 2013 Oct 3.
8
Evaluation of GeneXpert vanA/vanB in the early diagnosis of vancomycin-resistant enterococci infection.GeneXpert vanA/vanB 在万古霉素耐药肠球菌感染早期诊断中的评价。
PLoS Negl Trop Dis. 2021 Nov 8;15(11):e0009869. doi: 10.1371/journal.pntd.0009869. eCollection 2021 Nov.
9
Evaluation of GeneOhm VanR and Xpert vanA/vanB molecular assays for the rapid detection of vancomycin-resistant enterococci.评估 GeneOhm VanR 和 Xpert vanA/vanB 分子检测法快速检测万古霉素耐药肠球菌。
Eur J Clin Microbiol Infect Dis. 2012 Mar;31(3):273-6. doi: 10.1007/s10096-011-1306-y. Epub 2011 Jun 12.
10
Evaluation of the Xpert vanA/vanB assay using enriched inoculated broths for direct detection of vanB vancomycin-resistant Enterococci.采用富集接种肉汤直接检测 vanB 型万古霉素耐药肠球菌的 Xpert vanA/vanB 检测法评估。
J Clin Microbiol. 2014 Dec;52(12):4293-7. doi: 10.1128/JCM.01125-14. Epub 2014 Oct 8.

引用本文的文献

1
Evaluation of GeneXpert vanA/vanB in the early diagnosis of vancomycin-resistant enterococci infection.GeneXpert vanA/vanB 在万古霉素耐药肠球菌感染早期诊断中的评价。
PLoS Negl Trop Dis. 2021 Nov 8;15(11):e0009869. doi: 10.1371/journal.pntd.0009869. eCollection 2021 Nov.

本文引用的文献

1
Risk factors for intestinal colonization with vancomycin resistant enterococci' A prospective study in a level III pediatric intensive care unit.耐万古霉素肠球菌肠道定植的危险因素:一项在三级儿科重症监护病房的前瞻性研究
J Lab Physicians. 2018 Jan-Mar;10(1):89-94. doi: 10.4103/JLP.JLP_32_17.
2
Weekly screening supports terminating nosocomial transmissions of vancomycin-resistant enterococci on an oncologic ward - a retrospective analysis.每周筛查有助于终止肿瘤病房耐万古霉素肠球菌的医院内传播——一项回顾性分析
Antimicrob Resist Infect Control. 2017 May 16;6:48. doi: 10.1186/s13756-017-0206-z. eCollection 2017.
3
Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis.万古霉素耐药肠球菌定植、危险因素和感染风险:系统评价和荟萃分析。
Int J Antimicrob Agents. 2017 May;49(5):565-572. doi: 10.1016/j.ijantimicag.2017.01.008. Epub 2017 Mar 20.
4
Screening for vancomycin-resistant enterococci with Xpert® : diagnostic accuracy and impact on infection control decision making.使用Xpert®检测耐万古霉素肠球菌:诊断准确性及对感染控制决策的影响
New Microbes New Infect. 2017 Jan 12;16:54-59. doi: 10.1016/j.nmni.2016.12.020. eCollection 2017 Mar.
5
Evaluation of the novel artus C. difficile QS-RGQ, VanR QS-RGQ and MRSA/SA QS-RGQ assays for the laboratory diagnosis of Clostridium difficile infection (CDI), and for vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) screening.评估新型阿图斯艰难梭菌QS-RGQ、万古霉素耐药肠球菌VanR QS-RGQ和耐甲氧西林金黄色葡萄球菌MRSA QS-RGQ检测法用于艰难梭菌感染(CDI)的实验室诊断以及耐万古霉素肠球菌(VRE)和耐甲氧西林金黄色葡萄球菌(MRSA)筛查的效果。
Eur J Clin Microbiol Infect Dis. 2017 May;36(5):823-829. doi: 10.1007/s10096-016-2867-6. Epub 2016 Dec 16.
6
Screening for Intestinal Colonization with Vancomycin Resistant Enterococci and Associated Risk Factors among Patients Admitted to an Adult Intensive Care Unit of a Large Teaching Hospital.大型教学医院成人重症监护病房患者耐万古霉素肠球菌肠道定植筛查及相关危险因素分析
J Clin Diagn Res. 2016 Sep;10(9):DC06-DC09. doi: 10.7860/JCDR/2016/20562.8418. Epub 2016 Sep 1.
7
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management.耐万古霉素肠球菌感染:流行病学、临床表现及最佳管理
Infect Drug Resist. 2015 Jul 24;8:217-30. doi: 10.2147/IDR.S54125. eCollection 2015.
8
Infection control practices in patients with hematological malignancies and multidrug-resistant organisms: special considerations and challenges.血液系统恶性肿瘤患者与多重耐药菌的感染控制措施:特殊考量与挑战
Clin Lymphoma Myeloma Leuk. 2014 Sep;14 Suppl:S104-10. doi: 10.1016/j.clml.2014.06.021.
9
Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.血液学和肿瘤学恶性肿瘤患者中由耐万古霉素肠球菌(VRE)和产超广谱β-内酰胺酶肠杆菌科细菌(ESBLE)引起的肠道定植和血流感染
Infection. 2013 Oct;41(5):1039-40. doi: 10.1007/s15010-013-0434-y. Epub 2013 Mar 9.
10
Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.血液系统恶性肿瘤和恶性肿瘤患者的万古霉素耐药肠球菌(VRE)和产超广谱β-内酰胺酶肠杆菌科(ESBLE)引起的肠道定植和血流感染。
Infection. 2012 Dec;40(6):613-9. doi: 10.1007/s15010-012-0269-y. Epub 2012 Jun 5.